Xponance Inc., Richard Bernstein Advisors LLC, TD Private Client Wealth LLC, Concurrent Investment Advisors LLC, Alta Advisers Ltd, Ameritas Advisory Services LLC, Mezzasalma Advisors LLC, Invesco LLC, and Heartland Bank & Trust Co have all increased their stake in The Allstate Corporation (NYSE: ALL) indicating market optimism. Conversely, Stratos Wealth Partners LTD., Financial Counselors Inc., Kintegral Advisory LLC, Leeward Investments LLC, Principal Financial Group Inc., Strategic Financial Concepts LLC, D.A. Davidson & CO., Keybank National Association, KBC Group NV, Bank of New York Mellon Corp, Illinois Municipal Retirement Fund, Yardley Wealth Management LLC, Robeco Institutional Asset Management B.V, Oppenheimer Asset Management Inc., and Transcend Capital Advisors LLC sold their shares. Allstate's Financial Instruments offer promising opportunities while the sale of Group Health led to $500M gain. Price target has been adjusted by Autonomous Research to $186. The company showcased strong revenue growth in its Q1 2025 earnings call. Yet, Wall Street Zen downgraded the stock to hold, possibly due to worries over catastrophe impact reported in the Q1 2025 earnings call. It's speculated Allstate may not see a significant CEO pay rise this year. Its share repurchase authorization and dividend hike indeed enhance investor returns.
The Allstate Corporation ALL News Analytics from Wed, 25 Dec 2024 08:00:00 GMT to Sat, 12 Jul 2025 10:57:33 GMT -
Rating 0
- Innovation 1
- Information 7
- Rumor 3
